Based in Copenhagen, Denmark, Genmab is a biotechnology firm focused on creating antibody therapeutics for cancer and other serious diseases. It is known for DARZALEX, a treatment for multiple myeloma, among other innovative drugs targeting various cancers and conditions like thyroid eye disease and NSCLC. With a robust pipeline that includes treatments for blood cancers, solid tumors, and diseases like celiac and haemophilia A, Genmab collaborates with industry leaders like Seagen Inc., argenx, and AbbVie to advance medical research and treatment options.
With all eyes locked on this morning's CPI release and the Strait of Hormuz nearly shut down, Wall Street analysts are already repositioning across hospitality, pharma, and tech before the market even…
Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before, it all depends on the status of the war with Iran and…
Pre-Market Stock Futures: The futures are trading lower after a dreadful Friday and week, one that could be laying the foundation for a larger and more intense sell-off. The combination of the…
